Bay Area Virus Network

4th Annual Bay Area Symposium on Viruses

May 30, 2014 @ UC Berkeley

Innovation for Global Health

Diagnostics by Design Workshop

Videos of Keynote Speakers and Panel Discussion Now Available

Student Fellowships

UC Berkeley MHIRT

Students Blog from Around the World

Hack Day Success

Diagnostics by Design

Five Teams Compete in Diagnostics by Design Hack-a-thon

Want to stay connected?

Stories of Success

jay-keaslingOn April 11, 2013, the pharmaceutical company Sanofi launched the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today’s frontline anti-malaria drug based on Dr. Jay Keasling’s discovery at UC Berkeley.

To read more about this story, visit the UC Berkeley News Center.

More Stories

Henry Wheeler Center for Emerging and Neglected Diseases (CEND)

The Henry Wheeler Center for Emerging & Neglected Diseases (CEND) was established as a multi-disciplinary research unit in 2008, with the support of a generous donation by Henry H. “Sam” Wheeler, Jr. The mission of CEND is to help the University of California, Berkeley make innovative and substantial contributions to the global response to emerging and neglected infectious diseases. We at CEND believe that by educating potential innovators, connecting researchers from diverse disciplines, and investing in research, we can help the best and brightest minds at UC Berkeley access the resources they need to make meaningful and innovative contributions to our scientific understanding and ability to combat emerging and neglected diseases.

FEATURED VIDEO: Time-lapse video of teams building at the 2014 hack day for global health

TOP UA-36873340-1